ConductScience.org, home

Paper1998990

A clinical study of nafazatrom in advanced human breast cancer.

Jones AL and 3 others. Cancer Chemother Pharmacol, 1991. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. A clinical study of nafazatrom in advanced human breast cancer. Papers, record 1998990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1998990

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A clinical study of nafazatrom in advanced human breast cancer.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.06
iCite
Revised in PubMed
2019-08-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jones ALA L
2Powles TJT J
3Forgeson GVG V
4Coombes RCR C

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Breast NeoplasmsMajor topic
PyrazolesMajor topic
PyrazolonesMajor topic
Aged
Drug Evaluation
Female
Humans
Middle Aged
Prostaglandins

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13818230Phase I clinical study of nafazatrom.Invest New Drugs1986https://conductscience.org/library/papers/3818230PubMed
25246932Antimetastatic effects associated with platelet reduction.Proc Natl Acad Sci U S A1968https://conductscience.org/library/papers/5246932PubMed
3428423Biotransformation and cardiovascular effects of arachidonic acid in the dog.Eur J Pharmacol1979https://conductscience.org/library/papers/428423PubMed
47015512Prostacyclin: a potent antimetastatic agent.Science1981https://conductscience.org/library/papers/7015512PubMed
57220548Prostaglandin analogs as inhibitors of tumor cell DNA synthesis.Proc Soc Exp Biol Med1981https://conductscience.org/library/papers/7220548PubMed
63717082A clinical trial of nafazatrom (Bay g 6575) in advanced cancer.Am J Clin Oncol1986https://conductscience.org/library/papers/3717082PubMed
7594368Dose dependent inhibition of B-16 melanoma growth in vivo by a synthetic analogue of PGE2.Prostaglandins1977https://conductscience.org/library/papers/594368PubMed
8856236Assessment of response to therapy in advanced breast cancer.Br J Cancer1977https://conductscience.org/library/papers/856236PubMed
96469495Phase I and pharmacologic evaluation of nafazatrom in patients with cancer.Invest New Drugs1984https://conductscience.org/library/papers/6469495PubMed
107362778Influence of prostaglandin analogues on epithelial cell proliferation and xenograft growth.Br J Cancer1980https://conductscience.org/library/papers/7362778PubMed
11995190Inhibition of tumour growth in vivo and in vitro by prostaglandin E.Nature1976https://conductscience.org/library/papers/995190PubMed
122936443Clinical study of a new antimetastatic compound, Nafazatrom (Bay g 6575). Effects on platelet consumption and monocyte prostaglandin production in patients with advanced cancer.Cancer1986https://conductscience.org/library/papers/2936443PubMed
136362850Effects of prostacyclin on tumor cell-induced platelet aggregation.Cancer Res1984https://conductscience.org/library/papers/6362850PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
1423825Clinical significance of prostacyclin and thromboxane in cancer of the female breast and genital tract.Cancer Metastasis Rev1992https://conductscience.org/library/papers/1423825

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1998990

GET https://conductscience.org/api/papers/v1/1998990/authors